RAYSEARCH ENTERS AGREEMENT WITH SUMITOMO FOR BORON NEUTRON CAPTURE THERAPY
RaySearch and Sumitomo Heavy Industries, Ltd. (Sumitomo), based in Tokyo, Japan, have entered into an agreement regarding treatment planning for boron neutron capture therapy (BNCT) – a unique type of radiation therapy that targets cancer at the cellular level. The agreement extends the existing cooperation between Sumitomo and RaySearch on proton therapy.Sumitomo has developed the world’s first accelerator-based clinical BNCT system and is conducting clinical trials regarding recurrent head-and-neck and brain cancers in Japan. Treatment planning is an essential aspect of BNCT, and